Freeline Therapeutics (FRLN)
NASDAQ: FRLN
· Real-Time Price · USD
6.49
0.01 (0.15%)
At close: Feb 16, 2024, 9:37 PM
Freeline Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.09M | -16.01M | 1.17M | -23M | -14.89M | -24.35M | -26.73M | -34.7M | -30.88M | -39.87M | -34.95M |
Depreciation & Amortization | 386K | 433K | 320K | 315K | 406K | 479K | 541K | 611K | 588K | 618K | 573K |
Stock-Based Compensation | 895K | 1.07M | 973K | 1.04M | 1.2M | 1.46M | 1.38M | 1.85M | 3.18M | 3.14M | 2.55M |
Other Working Capital | 1.01M | 2.2M | -2.71M | 1.63M | 1.64M | 6.39M | -6.03M | 15.25M | 3.08M | 3.92M | 288K |
Other Non-Cash Items | 15K | -2.29M | -20.28M | 88K | -5.29M | 155K | 71K | 146K | -1K | n/a | 3K |
Deferred Income Tax | n/a | n/a | n/a | -156K | n/a | n/a | n/a | 35K | n/a | n/a | -206K |
Change in Working Capital | 2.12M | -486K | -621K | 1.86M | 3.41M | 5.63M | -1.84M | 14.76M | 4.42M | 2.75M | -2.19M |
Operating Cash Flow | -8.67M | -17.28M | -18.44M | -19.85M | -15.17M | -16.62M | -26.58M | -17.29M | -22.68M | -33.36M | -34.22M |
Capital Expenditures | -6K | -256K | -392K | -3.9M | -2.18M | -413K | -526K | -636K | -978K | -380K | -2.28M |
Cash Acquisitions | -46.4K | -4.03K | 24.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 46.4K | 66.03K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6K | -194K | 23.81M | -3.9M | -2.18M | -413K | -526K | -636K | -978K | -380K | -2.28M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 78.49K | 84.78K | n/a | 88K | -119.03K | 2.17M | 25.25M | -1.09M | -837.13 | 105K | n/a |
Financial Cash Flow | 39.19K | 32K | -91.83K | 88K | -3K | 2.19M | 25.25M | -1.09M | -1K | 105K | n/a |
Net Cash Flow | -9.35M | -16.62M | 6.51M | -18.45M | -24.23M | -23.19M | -4.58M | -18.75M | -28.34M | -31.06M | -34.36M |
Free Cash Flow | -8.68M | -17.53M | -18.83M | -23.75M | -17.35M | -17.03M | -27.11M | -17.93M | -23.66M | -33.74M | -36.5M |